Aktiesnakken — Marts 2010
-
wintrade newsticker skriver: Genmab har haft tocifret antal henvendelser vedrørende fabrik
-
regner med salgspris på 750 mio
-
halvdelen af oms guidance er deferred income
-
dvs ~200 mio deferred income
-
og kun 100-200 i milestones
-
lisa vil virkelig ikke ud med de oplysninger
-
kunne vi kke få en kommentar fra hunden i stedet
-
sagde de lige at de var ved at analysere data på egfr
-
ENS - igang med at analysere data, eller har i ikke set dem
-
sagde hun, at de havde fået data?
-
yep, de er ved at analysere data.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind